Please note that the publication of presentations is at the discretion of the speaker. While DCAT requests that all speakers provide their presentations for our website, it is the choice of each individual speaker whether to allow their presentations to be made public.

6th Annual DCAT International Business Development Forum:  Business Development in the Developing World: Case Studies in Sourcing Drugs for Global Pandemics

Supply Chain Challenges and Opportunities in Developing World Diseases
Wendy Woods, Partner and Managing Director, The Boston Consulting Group

Facilitating access to Safe, Effective Quality Medicines through Prequalification
Adrian J. van Zyl, Ph.D., Technical Officer Prequalification Program, Priority Essential Medicines, World Health Organization

A New Approach to Expanding Access to Essential Medicines
Dai Ellis, Director, Drug Access Team, Clinton Foundation HIV/Aids Initiative

Challenges Faced in Balancing Social Objectives while Running the Antireroviral Business
Yasir Y. Rawjee, Ph.D., VP, Business Development, Matrix Laboratories Ltd.

Sourcing and Product Access for the Developing World
Richard Spoor, Senior Vice President of Global Procurement, Merck & Co. Inc.

Technology and Manufacturing Excellence – Supporting Customers in the Access-to-Medicine Markets
Uwe H. Boehlke, Ph.D., Chief Operating Officer of Lonza Exclusive Synthesis

Issues for Purchasing Contracts and Quality Agreements in the Generic Pharma Industry
Stephen D. Sayre, Esq. and Todd G. Gattoni, Esq., Dykema Law Firm, Chicago, IL.

REACH and Its Impact on the Pharmaceutical Supply Chain
Dr. Hans Schoolderman, Director of Sustainability & Climate Change Services, PricewaterhouseCoopers

DCAT’s 2008 “PharmaChem Outlook” presented by Thomson

Emerging Markets as Opportunities, Rather than Threats
Kate Kuhrt, Director, Generics and API Intelligence, Thomson Scientific

A Blurring Of The Lines? Is “innovator” or “generic” becoming harder to discern?
Mike Chace-Ortiz, Senior Director, Product Strategy, API Intelligence, Thomson Scientific

HEALTHCARE STOCK PERFORMANCE: Volatility from 2007 carries into 2008 …
Trends in Prescription Drug Use
Jeff Shacket, Vice President, Corporate Advisory Services, Thomson Financial
Foli Adadevoh, Director, Corporate Advisory Services, Thomson Financial

PERCEPTIONS vs REALITY:  Facts and Figures on the Generic Industry
David Harding, Sales Support Specialist, API Intelligence, Thomson Scientific

Pharma vs The Others: Quality of Scientific Publications
Lawrence Liberti, MS, RPh, RAC, Thomson Scientific

Drug Nutrient Depletion:  Its Affects and Remedies
Derrick M. DeSilva Jr., M.D.

The FDA:  Getting Your New Package & Alternate Raw Materials Approved
Deborah M. Thomas, Sr. Director of Regulatory Affairs, Americas Region, West Pharmaceutical Services, Inc.